ALTHOUGH POSITIONED AS A CONTRACT RESEARCH ORGANIZATION (CRO), R&D WILL TO BE THE DNA OF McSAF, AWARE THAT ITS FUTURE DEVELOPMENT, GROWTH & COMPETITIVENESS DEPENDS ON IT.
Aiming to be recognized as a French & European Leader in BioConjugate Chemistry, McSAF will pay specific attention to develop its expertise & products in this field, and notably through conducting or participating in cutting-edge programs.
Therefore, its first priorities was to develop a team with wide coverage of expertise (chemists with high level background in heterocyclic chemistry, medicinal chemistry, bio-conjugates chemistry, biochemists) and to maintain and develop closed affinity toward its unique environment, either in terms of regional infra-structures (in place or to come), than in a first order partner network, industrials and academics. Those priorities will of course being pursued, mainly through an active engagement in own R&D programs, IP & strategic partnerships development.
Here are some interesting links for you! Enjoy your stay :)